EUVIMEDEUVIMED entdecken
Crossref

Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment

Tithi Bhattacharyya, Pritam Das, Aasia Ansari, Adrij A Mohan, Yogesh Chandra, Kumar Pranav Narayan iD, Rajkumar Banerjee iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c00002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Tithi Bhattacharyya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oils, Lipids Science and Technology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, STAT3 Transcription Factor, Receptors, Glucocorticoid, Colonic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsSTAT3 Transcription FactorReceptors, GlucocorticoidColonic NeoplasmsAntineoplastic AgentsDexamethasoneBiocompatible MaterialsNiclosamideNanoparticlesAnimalsMiceLiposomesCell ProliferationDrug Screening Assays, AntitumorHumansParticle SizeMice, Inbred BALB CTumor MicroenvironmentDose-Response Relationship, Drug

Stichwörter der Autor:innen

Engineered Myeloid-derived suppressor cellsGR-targeted nanoliposomesbone marrow cellscolorectal cancerglucocorticoid receptor (GR)

Substanzen

STAT3 Transcription FactorReceptors, GlucocorticoidLiposomesAntineoplastic AgentsDexamethasoneBiocompatible MaterialsNiclosamide

Autor:innen und Institutionen

  • Division of Oils, Lipids Science and Technology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Department of Biotechnology, Manipal Institute of Technology, Manipal, Karnataka 576104, India.
  • Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
  • Department of Biological Sciences, BITS Pilani, Hyderabad Campus, Jawahar Nagar, Hyderabad 500078, India.

ORCID-Profile: Kumar Pranav Narayan, Rajkumar Banerjee

Förderung

  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Science and Engineering Research Board

Zitieren

APA

Bhattacharyya, T., Das, P., Ansari, A., Mohan, A. A., Chandra, Y., Narayan, K. P., & Banerjee, R. (2025). Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00002

Vancouver

Bhattacharyya T, Das P, Ansari A, Mohan AA, Chandra Y, Narayan KP, et al. Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00002

BibTeX
@article{Bhattacharyya2025,
  author = {Bhattacharyya, Tithi and Das, Pritam and Ansari, Aasia and Mohan, Adrij A and Chandra, Yogesh and Narayan, Kumar Pranav and Banerjee, Rajkumar},
  title = {Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c00002}
}
Kostenlos starten →